These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 5018978)

  • 1. A comparative study of the behavioral effects of scopolamine and 4-(1-naphthylvinyl) pyridine hydrochloride (NVP), an inhibitor of choline acetyltransferase.
    Goldberg ME; Sledge K; Robichaud RC; Dubinsky B
    Psychopharmacologia; 1972; 23(1):34-47. PubMed ID: 5018978
    [No Abstract]   [Full Text] [Related]  

  • 2. Learning impairment after three classes of agents which modify cholinergic function.
    Goldberg ME; Sledge K; Hefner M; Robichaud RC
    Arch Int Pharmacodyn Ther; 1971 Oct; 193(2):226-35. PubMed ID: 5119213
    [No Abstract]   [Full Text] [Related]  

  • 3. A pharmacological analysis of processes underlying differential responding: a review and further experiments with scopolamine, amphetamine, lysergic acid diethylamide (LSD-25), chlordiazepoxide, physostigmine, and chlorpromazine.
    Frontali M; Amorico L; De Acetis L; Bignami G
    Behav Biol; 1976 Sep; 18(1):1-74. PubMed ID: 791242
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of choline acetyltransferase and hexobarbitone-metabolizing enzymes by naphthylvinyl pyridine analogues.
    Goldberg ME; Salama AI; Blum SW
    J Pharm Pharmacol; 1971 May; 23(5):384-5. PubMed ID: 4396988
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of 4-(1-naphthylvinyl)-pyridine (NVP), a choline acetylase inhibitor, on autonomically innervated tissues of the rat.
    Clark AL; Mitchelson F
    Eur J Pharmacol; 1974 Jun; 27(1):34-9. PubMed ID: 4854792
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment to effects of scopolamine on avoidance conditioning and habituation of mice.
    Oliverio A; Meyers B
    Psychopharmacologia; 1968; 13(4):354-5. PubMed ID: 5722172
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of a choline acetyltransferase inhibitor on self-stimulatory behavior in the rat.
    Malick JB; Goldberg ME
    Arch Int Pharmacodyn Ther; 1970 Apr; 184(2):252-6. PubMed ID: 5453230
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological analysis of a specific cholinacetylase inhibitor].
    Stern P
    Arzneimittelforschung; 1971 Jul; 21(7):991-3. PubMed ID: 5109516
    [No Abstract]   [Full Text] [Related]  

  • 9. Amnesic effects of scopolamine.
    Glick SD; Zimmerberg B
    Behav Biol; 1972 Apr; 7(2):245-54. PubMed ID: 5064951
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies with agents which influence acetylcholine metabolism in mouse brain.
    Saelens JK; Simke JP; Schuman J; Allen MP
    Arch Int Pharmacodyn Ther; 1974 Jun; 209(2):250-8. PubMed ID: 4441166
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of physostigmine and scopolamine on operant brightness discrimination in the rat.
    Leaton RN; Kreindler M
    Physiol Behav; 1972 Jul; 9(1):121-3. PubMed ID: 5080149
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the side arm of (naphthylvinyl)pyridinium inhibitors of choline acetyltransferase.
    DeBernardis JF; Gifford P; Rizk M; Ertel R; Abraham DJ; Siuda JF
    J Med Chem; 1988 Jan; 31(1):117-21. PubMed ID: 3336013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental manipulation of acetylcholine levels in developing rat brain: neurochemistry and behavior.
    Mathura CB; Meier GW; Himwich WA
    Psychol Rep; 1979 Dec; 45(3):811-8. PubMed ID: 538197
    [No Abstract]   [Full Text] [Related]  

  • 14. EEG patterns during the behavioural desensitization to scopolamine in rats.
    Florio V; Bignami G; Longo VG
    Int J Neuropharmacol; 1969 Sep; 8(5):405-11. PubMed ID: 5344486
    [No Abstract]   [Full Text] [Related]  

  • 15. An analysis of the learning deficits produced by scopolamine.
    Berger BD; Stein L
    Psychopharmacologia; 1969; 14(4):271-83. PubMed ID: 5389067
    [No Abstract]   [Full Text] [Related]  

  • 16. Conditioning of food aversions by injections of psychoactive drugs.
    Berger BD
    J Comp Physiol Psychol; 1972 Oct; 81(1):21-6. PubMed ID: 5074304
    [No Abstract]   [Full Text] [Related]  

  • 17. Short-term memory: facilitation and disruption with cholinergic agents.
    Alpern HP; Marriott JG
    Physiol Behav; 1973 Oct; 11(4):571-5. PubMed ID: 4743228
    [No Abstract]   [Full Text] [Related]  

  • 18. Some actions of cholinergic and anticholinergic drugs on reactive behavior.
    Herz A
    Prog Brain Res; 1968; 28():73-85. PubMed ID: 5699593
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of cholinergic activity and the aversive threshold in the rat.
    Houser VP; Van Hart DA
    Pharmacol Biochem Behav; 1974; 2(5):631-7. PubMed ID: 4431827
    [No Abstract]   [Full Text] [Related]  

  • 20. Delayed matching-to-sample performance by rats in a new avoidance-motivated maze: response to scopolamine and fimbria-fornix lesions.
    Bresnahan EL; Wiser PR; Muth NJ; Ingram DK
    Physiol Behav; 1992 Apr; 51(4):735-46. PubMed ID: 1594672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.